Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance

Proceedings of the National Academy of Sciences, Volume 123, Issue 10, March 2026. <br/>SignificanceGlucocorticoids (GCs) are widely used in clinical oncology to manage inflammation, edema, and therapy-related adverse effects, but their profound immunosuppressive properties can inadvertently impair anticancer immunity. This study identifies …